02536nam 22005053 450 991096711780332120251017110101.00-309-08882-80-309-08876-3(MiAaPQ)EBC6874739(Au-PeEL)EBL6874739(CKB)21004382600041(NjHacI)9921004382600041(OCoLC)1296428832(DNLM)9918382876506676(EXLCZ)992100438260004120220131d2021 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierCountering the Pandemic Threat Through Global Coordination on Vaccines The Influenza Imperative1st ed.Washington, D.C. :National Academies Press,2021.©2022.1 online resource (237 pages)0-309-08870-4 Intro -- FrontMatter -- Reviewers -- National Academy of Medicine: Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response Series -- Acknowledgments -- Preface -- Contents -- Boxes, Figures, and Tables -- Acronyms and Abbreviations -- Summary -- 1 Introduction: The Imperative for Global Investment in Influenza Vaccines -- 2 The Existing Global Governance Landscape for Influenza Vaccines -- 3 Pathogen Sharing for Influenza Vaccine Production -- 4 Technology and Manufacturing Partnerships -- 5 Influenza Vaccine Access and Financing -- 6 Recommendations and the Path Forward -- Appendix A: Committee and Staff Biographies -- Appendix B: Committee Meeting Agendas.Introduction : the imperative for global investment in influenza vaccines -- The existing global governance landscape for influenza vaccines -- Pathogen sharing for influenza vaccine production -- Technology and manufacturing partnerships -- Influenza vaccine access and financing -- Recommendations and the path forward.InfluenzaInfluenza.616.203Sands Peter1802099Winters Janelle1802100Sands Peter1802099National Academies of Sciences, Engineering, and Medicine.Committee on Global Coordination, Partnerships, and Financing.MiAaPQMiAaPQMiAaPQBOOK9910967117803321Countering the Pandemic Threat Through Global Coordination on Vaccines4347630UNINA